Cognito Therapeutics Announces Oral Presentation on Spectris Therapy Open-Label Study Data in Alzheimer's Disease at AD/PD 2024

CAMBRIDGE, Mass., February 28, 2024--Cognito Therapeutics Announces Oral Presentation on Spectris Therapy Open-Label Study Data in Alzheimer’s Disease at AD/PD 2024

Related Keywords

Lisbon ,Lisboa ,Portugal ,Cambridge ,Cambridgeshire ,United Kingdom ,Brent Vaughan ,Ralph Kern ,International Conference On Alzheimer ,Cognito Therapeutics ,Room Auditorium ,Chief Medical Officer ,